Danaher Co. (DHR) Holdings Reduced by AGF Investments Inc.
AGF Investments Inc. lowered its position in Danaher Co. (NYSE:DHR) by 1.3% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 259,699 shares of the conglomerate’s stock after selling 3,539 shares during the quarter. AGF Investments Inc.’s holdings in Danaher were worth $24,105,000 as of its most recent SEC filing.
A number of other hedge funds have also recently modified their holdings of the business. Associated Banc Corp lifted its holdings in Danaher by 0.5% in the 4th quarter. Associated Banc Corp now owns 282,149 shares of the conglomerate’s stock worth $26,190,000 after buying an additional 1,327 shares in the last quarter. Evermay Wealth Management LLC lifted its holdings in Danaher by 85.8% in the 4th quarter. Evermay Wealth Management LLC now owns 12,874 shares of the conglomerate’s stock worth $1,195,000 after buying an additional 5,944 shares in the last quarter. NuWave Investment Management LLC acquired a new position in Danaher in the 4th quarter worth $862,000. Wealthstreet Investment Advisors LLC acquired a new position in Danaher in the 4th quarter worth $639,000. Finally, Whittier Trust Co. of Nevada Inc. lifted its holdings in Danaher by 2.8% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 28,681 shares of the conglomerate’s stock worth $2,662,000 after buying an additional 782 shares in the last quarter. Hedge funds and other institutional investors own 75.88% of the company’s stock.
In other Danaher news, SVP Daniel Raskas sold 37,870 shares of the company’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $93.33, for a total value of $3,534,407.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP William K. Daniel sold 131,066 shares of the company’s stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $102.05, for a total transaction of $13,375,285.30. Following the completion of the transaction, the executive vice president now owns 270,523 shares of the company’s stock, valued at approximately $27,606,872.15. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 274,913 shares of company stock valued at $27,729,293. Insiders own 12.20% of the company’s stock.
Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.16 by $0.03. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The business had revenue of $5.09 billion during the quarter, compared to the consensus estimate of $4.97 billion. During the same quarter in the prior year, the firm earned $1.05 EPS. The company’s revenue for the quarter was up 10.9% compared to the same quarter last year. research analysts expect that Danaher Co. will post 4.37 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Friday, December 29th were given a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.59%. The ex-dividend date was Thursday, December 28th. Danaher’s dividend payout ratio is presently 16.00%.
DHR has been the subject of several research analyst reports. Cowen reissued a “buy” rating and issued a $110.00 target price on shares of Danaher in a research report on Tuesday, January 30th. Credit Suisse Group boosted their target price on shares of Danaher from $99.00 to $105.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Royal Bank of Canada reissued a “hold” rating and issued a $98.00 target price on shares of Danaher in a research report on Wednesday, January 31st. Morgan Stanley boosted their target price on shares of Danaher from $103.00 to $110.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 31st. Finally, Stifel Nicolaus boosted their target price on shares of Danaher from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Wednesday, January 31st. One analyst has rated the stock with a sell rating, five have given a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $100.13.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.